Delivery Order SPE2DR25D1100-SPE2DR26FCQ6F
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count unit doses. This firm fixed-price delivery order, issued on October 24, 2025, with completion scheduled for November 17, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors and...
- The Defense Logistics Agency has awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for OJJAARA 100 mg tablets in quantities of 30, with a contract ceiling value of $17,912.32. This firm fixed-price delivery order, set to be completed by August 14, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $17,849.85 on September 9, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-set-aside, competitively awarded contract supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $17,281.01 to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in 30-count units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of December 12, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award involves no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete successfully in...
- The Defense Logistics Agency awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp on September 26, 2025, for supply of Ojjaara 200 mg tablets in 30-count units. This firm fixed price contract, with an ultimate completion date of October 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order was competitively awarded with no...
- The Defense Logistics Agency (DLA) awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. The contract, which represents a child award under AmerisourceBergen's larger IDC with DLA, is scheduled for completion by August 25, 2025. The award was made on a competitive basis with no set-aside designation, and the pharmaceutical products will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for 200 mg Ojjaara tablets in quantities of 30 units, with an ultimate completion date of July 7, 2025. This firm fixed-price delivery order, issued on June 12, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,912.32 by the Defense Logistics Agency's Medical Supply Chain to supply OJJAARA 100 mg tablets in packages of 30 units. This firm fixed-price contract, awarded on August 28, 2025, with a completion date of September 19, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCQ6FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,281.01 to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-unit packages. This firm fixed-price delivery order, issued on November 20, 2025, is scheduled for completion by December 12, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the Defense Logistics Agency's Medical Supply Chain with a comprehensive portfolio of pharmaceutical products supporting military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. The company's consistent success in securing competitive federal contracts demonstrates its capability to fulfill federal medical supply requirements, positioning it as a key vendor within the Defense Logistics Agency's pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 11/20/25 |